ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Brimonidine Labatec 2 mg/ml, collyre en solution - 5 ml
68527001 Labatec Pharma SA
Brimonidine Labatec 2 mg/ml, collyre en solution18.01.2023
  18.01.2023
Brimonidine (S01EA05) 
WHO-DDD17.01.2028
5 ml
11.09. 
B  
No 
IP 
PR  
k.A.PR
  
7680685270016Synthetika
  
Composition
brimonidini tartras 2 mg corresp. brimonidinum 1.3 mg, poly(alcohol vinylicus), natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, benzalkonii chloridum 50 µg, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
collyre en solution
 
 
Active AgentDose
Brimonidine Tartrate2 mg/ml correspond Brimonidine 1.3 mg/ml
 
Inactive agentsDose
Citric Acid Monohydrate 
Acidum Hydrochloridum aut Natrii Hydroxidum ad Ph 
Benzalkonium Chloride50 µg/ml
Sodium Chloride 
Natrii Citras Dihydricus 
Poly(Alcohol Vinylicus) 
Source
Data was imported : 07.02.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home